Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

Background Neoadjuvant chemoradiotherapy followed by esophagogastrectomy has become the standard of care for patients with locally advanced esophageal cancer. This report analyzes our experience with this treatment approach. Methods From January 1998 through December 2003, all patients from a single...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of thoracic surgery 2009-02, Vol.87 (2), p.392-399
Hauptverfasser:	Donahue, James M., MD, Nichols, Francis C., MD, Li, Zhuo, MS, Schomas, David A., MD, Allen, Mark S., MD, Cassivi, Stephen D., MD, Jatoi, Aminah, MD, Miller, Robert C., MD, Wigle, Dennis A., MD, PhD, Shen, K. Robert, MD, Deschamps, Claude, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - therapy Adult Age Factors Aged Aged, 80 and over Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Cardiothoracic Surgery Chemotherapy, Adjuvant Cohort Studies Confidence Intervals Disease-Free Survival Esophageal Neoplasms - mortality Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Esophagectomy - methods Female Humans Immunohistochemistry Kaplan-Meier Estimate Male Middle Aged Neoadjuvant Therapy Neoplasm Staging Preoperative Care - methods Probability Prognosis Radiotherapy, Adjuvant Retrospective Studies Risk Assessment Sex Factors Surgery Survival Analysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!